Alterity Therapeutics ATHE
NASDAQ ATHE
$2.31 +0.01 (+0.43%)
As of: Nov 11, 2026 · 3:59 PM EST

Alterity Therapeutics (ATHE) Current Leases (2020 - 2024)

Updated

Alterity Therapeutics (ATHE) recorded Current Leases of -$137,235 in the quarter ended Jun 30, 2026, compared with $56,707 a year earlier.

Analysis

Alterity Therapeutics (ATHE) Current Leases (2020 - 2024) Analysis & Trends

Starting with the quarter ended Jun 30, 2020, Alterity Therapeutics' Current Leases history includes 9 quarters.

  • Across earlier years, Current Leases came in at $56,707 in the year ended Jun 30, 2025, $519.14 in the year ended Jun 30, 2024 (-49.7%), $1,032 in the year ended Jun 30, 2023 (-97.6%) and $42,874 in the year ended Jun 30, 2022 (+46.9%).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Current Leases in data going back to the quarter ended Jun 30, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Alterity Therapeutics 42.05 Mn -41.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 39,007.48
Jun 30, 2024 71,248.53
Jun 30, 2021 58,354.37
Jun 30, 2020 53,370.67
API Access

Alterity Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ATHE&period=max&api_key=YOUR_API_KEY